The assignment of human leucocyte antigens (HLAs) against which antibodies are detected as unacceptable antigens (UAGs) avoids allocation of HLA- incompatible allografts. There is uncertainty as to what extent UAGs decrease the probability of receiving a kidney offer. Kidney transplantations in 3264 patients on the waiting lists of six German transplant centres were evaluated for a period of at least 2 years. The proportion of excluded offers due to UAGs was calculated as virtual panel-reactive antibodies (vPRAs). In the common Eurotransplant Kidney Allocation Scheme, the transplant probability was unaffected by vPRAs in exploratory univariate analyses. In the multivariable model, a 1% increase in vPRA values was outweighed by an additional waiting time of 2.5 weeks. The model was confirmed using an external validation cohort of 1521 patients from seven centres. If only patients with standard risk were considered (e.g. no simultaneous transplantation of other organs), only 1.3 weeks additional waiting time was needed. In the Eurotransplant Senior Program, patients with vPRA values >50% had a strongly reduced transplant probability in the unadjusted analyses. In the multivariable model, a 1% increase in vPRA values was outweighed by an additional waiting time of 5 weeks. This study demonstrates that the assignment of UAGs decreases the transplant probability in both main Eurotransplant allocation programs because of insufficient compensatory mechanisms. At present, for immunized patients, a prolonged waiting time has to be weighed against the increased immunologic risk due to donor-specific antibodies not assigned as UAGs.
Purpose of review: Data and interventional trials on vasopressor use during cardiogenic shock are scarce. Their use is limited by their side-effects and the lack of solid evidence regarding their effectiveness in improving outcomes. In the present article, we review the current use of vasopressor therapy during cardiogenic shock. Recent findings: Two recent Cochrane analyses concluded that there was insufficient evidence to prove that any one vasopressor was superior to others in terms of mortality. A recent RCT and a meta-analysis on individual data suggested that norepinephrine may be preferred over epinephrine in patients with cardiogenic shock, in particular, after myocardial infarction. In patients with right ventricular failure and pulmonary hypertension, the use of vasopressin may be advocated under advanced monitoring. Summary: When blood pressure needs to be restored, norepinephrine is a reasonable first-line agent. Information regarding comparative effective outcomes is sparse and their use should be limited to a temporary measure as a bridge to recovery, mechanical circulatory support or heart transplantation.
Fabry disease (FD) is a lysosomal storage disorder of X-linked inheritance. Mutations in the α-galactosidase A gene lead to cellular globotriaosylceramide (Gb3) depositions and triggerable acral burning pain in both sexes as an early FD symptom of unknown pathophysiology. We aimed at elucidating the link between skin cells and nociceptor sensitization contributing to FD pain in a sex-associated manner. We used cultured keratinocytes and fibroblasts of 27 adult FD patients and 20 healthy controls. Epidermal keratinocytes and dermal fibroblasts were cultured and immunoreacted to evaluate Gb3 load. Gene expression analysis of pain-related ion channels and pro-inflammatory cytokines was performed in dermal fibroblasts. We further investigated electrophysiological properties of induced pluripotent stem cell (iPSC) derived sensory-like neurons of a man with FD and a healthy man and incubated the cells with interleukin 8 (IL-8) or fibroblast supernatant as an in vitro model system. Keratinocytes displayed no intracellular, but membrane-bound Gb3 deposits. In contrast, fibroblasts showed intracellular Gb3 and revealed higher gene expression of potassium intermediate/small conductance calcium-activated potassium channel 3.1 (KCa 3.1, KCNN4) in both, men and women with FD compared to controls. Additionally, cytokine expression analysis showed increased IL-8 RNA levels only in female FD fibroblasts. Patch-clamp studies revealed reduced rheobase currents for both iPSC neuron cell lines incubated with IL-8 or fibroblast supernatant of women with FD. We conclude that Gb3 deposition in female FD patient skin fibroblasts may lead to increased KCa3.1 activity and IL-8 secretion. This may result in cutaneous nociceptor sensitization as a potential mechanism contributing to a sex-associated FD pain phenotype.
Professional caregivers often suffer from post-traumatic stress disorder after intra-hospital cardiac arrest. The aim of our study was to describe long-term evolution of symptoms of anxiety among professional caregivers after a simulation-based training. Our study was a prospective, single-center pilot study conducted at Nancy-Brabois University Hospital. The sample included 56 professional caregivers, divided into two groups: 26 participants who underwent simulation-based training and 30 controls who did not participate during the study period. This sample size was determined based on the availability of participants and the exploratory nature of the pilot study. Each simulation involved a team of junior healthcare providers. Symptoms of anxiety and self-efficacy were assessed using standardized scales before, immediately after, and 3 months post-training. Control professional caregivers completed the same assessments without training. The symptoms of anxiety were assessed using the Spielberger State-Trait Anxiety Inventory (STAI) questionnaire while self-efficacy was assessed by Cardiopulmonary Resuscitation Self-Efficacy Scale (CPR-SES). Nine simulation-based training sessions were conducted, each including a team of professional caregivers (one junior physician, one junior nurse, and one care assistant). There was no significant difference in symptoms of anxiety immediately after training. However, after 3 months, both state and trait anxiety significantly decreased, while self-efficacy improved among the professional caregivers who attended the simulation-based training. Our study shows sustained behavioral improvements in professional caregivers after simulation-based training, enhancing their self-efficacy in cardiac arrest management. Further research is needed to evaluate the longevity and necessity of repeated training sessions.
27 August 2024 in Intensive Care Medicine Experimental
Background: Acute respiratory distress syndrome (ARDS) remains a significant challenge in critical care, with high mortality rates despite advancements in treatment. Venovenous extracorporeal membrane oxygenation (VV-ECMO) is employed as salvage therapy for refractory cases. However, some patients may continue to experience persistent severe hypoxemia despite being treated with VV-ECMO. To achieve this, moderate hypothermia and short-acting selective β1-blockers have been proposed. Methods: Using a swine model of severe ARDS treated with VV-ECMO, this study investigated the efficacy of moderate hypothermia or β-blockade in improving arterial oxygen saturation (SaO2) three hours after VV-ECMO initiation. Primary endpoints included the ratio of VV-ECMO flow to cardiac output and arterial oxygen saturation before VV-ECMO start (H0) and three hours after ECMO start (H3). Secondary safety criteria encompassed hemodynamics and oxygenation parameters. Results: Twenty-two male pigs were randomized into three groups: control (n = 6), hypothermia (n = 9) and β-blockade (n = 7). At H0, all groups demonstrated similar hemodynamic and respiratory parameters. Both moderate hypothermia and β-blockade groups exhibited a significant increase in the ratio of VV-ECMO flow to cardiac output at H3, resulting in improved SaO2. At H3, despite a decrease in oxygen delivery and consumption in the intervention groups compared to the control group, oxygen extraction ratios across groups remained unchanged and lactate levels were normal. Conclusions: In a swine model of severe ARDS treated with VV-ECMO, both moderate hypothermia and β-blockade led to an increase in the ratio of VV-ECMO flow to cardiac output resulting in improved arterial oxygen saturation without any impact on tissue perfusion.
Cardiac arrest is a major medical emergency with survival rates below 10%. Among care components after the return of spontaneous circulation (ROSC), sedation remains poorly standardized. Initial sedation may be withheld from the most severely ill patients in order to facilitate the early identification of neurological recovery. We analyzed data from the prospective AfterROSC1 and AfterROSC2 cohort studies. We compared post-cardiac arrest patients in whom sedation was vs. was not started during pre-hospital care. Patients' characteristics, day-90 survival, and day-90 survival with a favorable neurological outcome were analyzed (modified Rankin scale 0-3). The day-90 neurological outcome was adjusted for disease severity (modified Cardiac Arrest Hospital Prognosis score [mCAHP]) and for center effect. Of the 1596 included patients, 1324 (83%) were and 272 (17%) were not sedated before intensive-care-unit (ICU) admission. In both groups, males and cardiac arrest at home predominated. The mCAHP score was higher in the group without pre-ICU sedation (median: 90 [70-106] vs. 105 [90-116], P=0.001). The pre-ICU sedated group had a higher proportion of patients with a favorable day-90 outcome (32.4% vs. 11.8%; P=0.001). This difference remained significant after adjustment for the mCAHP score and center (adjusted odds ratio, 2.19; 95% confidence interval, 1.31-3.65; P=0.003) but not after propensity score adjustment: 1.40 [95%CI: 0.70 ; 2.09] (P = 0.26). The decision of sedation started after ROSC and before ICU admission was associated with a good functional recovery on day 90. However, the design of this study does not allow us to establish a causal link between pre-hospital sedation and improved neurological recovery. In particular, it is not possible to formally rule out residual indication bias. A randomized trial assessing the effect of early sedation on treatment strategies and patient outcomes is needed.